SCHEMBL23879558

SCHEMBL23879558

CN(C)CC(CO)OC(C)(C)C

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18819240 0.85
SCHEMBL6015013 0.80 PRKCA (0.37) PRKCA
SCHEMBL23179730 0.79
SCHEMBL12085775 0.76 MAPK1 (0.38)
SCHEMBL18027533 0.73 PRKCA (0.33) PRKCA
SCHEMBL224066 0.73 PRKCA (0.33) PRKCA
SCHEMBL14349630 0.73 PRKCA (0.33) PRKCA
SCHEMBL27055120 0.73 PRKCA (0.33) PRKCA
SCHEMBL12571474 0.73
SCHEMBL12216229 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11136339-B2 Dihydroartemisinin diploid derivative, pharmaceutical composition thereof, and application SOUTHEAST UNIVERSITY (CN) 2021-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11136339-B2 Dihydroartemisinin diploid derivative, pharmaceutical composition thereof, and application SSB, DHODH, QTRT1 PRKCA 3828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.